欢迎来到天天文库
浏览记录
ID:5346056
大小:250.15 KB
页数:3页
时间:2017-12-08
《糖耐量减低患者的转归及影响因素的logistic多元回归分析》由会员上传分享,免费在线阅读,更多相关内容在学术论文-天天文库。
1、第28卷第4期广东医学院学报、bI.28NO.43742010年8月J0URNALoFGINGDoNGMEDICALCOLLEGEAug.2010糖耐量减低患者的转归及影响因素的Logistic多元回归分析陈晓铭,武革,周飞,吴美芬,陈文璞(广东医学院附属医院内分泌科,广东湛江524001)摘要:目的观察糖耐量减低(roT)患者中糖尿病发生率及其危险因素。方法收集2005至2006年糖耐量减低患者355例,随机分为干预治疗组(n=166)和非干预治疗组=I89),出院后随访3a,统计糖尿病(I)发生率,用Logistc多元回归分析其危险因素。结果非干预治疗组中发生DM7
2、0例(37.0%),年转化率为12.3%;干预治疗组中发生DM24例(14.4%),年转化率为4.8%;两组比较差异有统计学意义(尸3、tivariatelogisticregressionanalysisforoutcomeandriskfactorsofimpairedglucosetolerancepatientsCHENXiao—ming,WUGe,ZHOUFei,WUMei-fen,CHENWen—pu(DepartmentofEndocrinology,AfiliatedHospitalofGuangdongMedicalCollege,Zha~iang524001,China)Abstract:ObjectiveToobservetheincidenceandriskfactorsofdi4、abetesmellitus(DM)inpatientswithimpairedglucoseto-lerance0GT).MethodsAtotalof355IGTpatientsenrolledfrom2005tO2006wererandomlydividedintocontrolgroup(n=189)andtreatmentgroup(n=166),andtheincidenceandriskfactorsofDMinbothgroupswereanalyzedbymultivariatelogisticregres—sionall-alysiswithin3-5、yearfollowed-up.ResultsTheincidenceandannualconversionrateofDMwere37.O%and12-3%incon-trolgroup.and14.4%and4.8%intreatmentgroup,respectively;therewerestatisticaldiflerencesbetweenbothgroups(p<0.05).TheriskfactorsofDMwere2hbloodglucose(DR:3.016),diabetesfamilyhistory(0.R=1.446)andage(O=1.16、76).ConclusionTheriskfactorsofDMinclude2hbloodglucose,diabetesfamilyhistoryandage,andearlyinterventionmayimprovetheprevalenceofDMinIGTpatients.Keywords:impairedglucosetolerance;diabetesmellitus;intervention糖耐量减低(IGT)属于糖尿病(DM)前期,其发展为DM的例、女87例,年龄35~76岁,平均年龄(51,6±8.3)岁;189例属几率明显高于正常糖耐量(NGT)7、者,因而越来越受到人们的IGTI12例,IGT/空腹血糖调节受损(IFG)77例。(2)干预治疗组:重视。有关IG璁者自然转归的相关影响因素及干预治疗后166例,男101例、女65例,年龄34-~72岁,平均年龄(50.8-t-7.7)的糖尿病发病率国内已有文献报道【”,但报道还不多,来自岁。两组在饮食与运动治疗的基础上,干预治疗组加用口服亚热带地区的报道目前尚未见迄文献。本文主要分析IGT患二甲双胍(250-500mg,每日3次,连服3a),非干预治疗组不者的自然转归及影响因素和观察用二甲双胍干预治疗其糖尿加用二甲双胍口}干预治疗组按不
3、tivariatelogisticregressionanalysisforoutcomeandriskfactorsofimpairedglucosetolerancepatientsCHENXiao—ming,WUGe,ZHOUFei,WUMei-fen,CHENWen—pu(DepartmentofEndocrinology,AfiliatedHospitalofGuangdongMedicalCollege,Zha~iang524001,China)Abstract:ObjectiveToobservetheincidenceandriskfactorsofdi
4、abetesmellitus(DM)inpatientswithimpairedglucoseto-lerance0GT).MethodsAtotalof355IGTpatientsenrolledfrom2005tO2006wererandomlydividedintocontrolgroup(n=189)andtreatmentgroup(n=166),andtheincidenceandriskfactorsofDMinbothgroupswereanalyzedbymultivariatelogisticregres—sionall-alysiswithin3-
5、yearfollowed-up.ResultsTheincidenceandannualconversionrateofDMwere37.O%and12-3%incon-trolgroup.and14.4%and4.8%intreatmentgroup,respectively;therewerestatisticaldiflerencesbetweenbothgroups(p<0.05).TheriskfactorsofDMwere2hbloodglucose(DR:3.016),diabetesfamilyhistory(0.R=1.446)andage(O=1.1
6、76).ConclusionTheriskfactorsofDMinclude2hbloodglucose,diabetesfamilyhistoryandage,andearlyinterventionmayimprovetheprevalenceofDMinIGTpatients.Keywords:impairedglucosetolerance;diabetesmellitus;intervention糖耐量减低(IGT)属于糖尿病(DM)前期,其发展为DM的例、女87例,年龄35~76岁,平均年龄(51,6±8.3)岁;189例属几率明显高于正常糖耐量(NGT)
7、者,因而越来越受到人们的IGTI12例,IGT/空腹血糖调节受损(IFG)77例。(2)干预治疗组:重视。有关IG璁者自然转归的相关影响因素及干预治疗后166例,男101例、女65例,年龄34-~72岁,平均年龄(50.8-t-7.7)的糖尿病发病率国内已有文献报道【”,但报道还不多,来自岁。两组在饮食与运动治疗的基础上,干预治疗组加用口服亚热带地区的报道目前尚未见迄文献。本文主要分析IGT患二甲双胍(250-500mg,每日3次,连服3a),非干预治疗组不者的自然转归及影响因素和观察用二甲双胍干预治疗其糖尿加用二甲双胍口}干预治疗组按不
此文档下载收益归作者所有